Class Action Lawsuit Filed Against Immutep Limited (NASDAQ: IMMP) for Alleged Securities Fraud
A securities class action lawsuit has been filed against Immutep Limited (IMMP), alleging violations of the Securities Exchange Act. The suit claims that false statements were made regarding a clinical trial, misleading investors between March 2025 and March 2026.

Tickers: $IMMP
Topics: class action lawsuit Rule 10b-5 Securities Exchange Act of 1934